Bugao, Neonita B.
HRN: 01-22-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2024
CEFTRIAXONE 1G (VIAL)
12/30/2024
01/05/2025
IV
2g
OD
T/C Iatrogenic Cushing Syndrome; T2DM: CKD Sec To DKD
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes